134 related articles for article (PubMed ID: 36942115)
1. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer.
Nepal SP; Nakasato T; Fukagai T; Ogawa Y; Nakagami Y; Shichijo T; Morita J; Maeda Y; Oshinomi K; Unoki T; Noguchi T; Inoue T; Kato R; Amano S; Mizunuma M; Kurokawa M; Tsunokawa Y; Yasuda S
Asian J Urol; 2023 Apr; 10(2):158-165. PubMed ID: 36942115
[TBL] [Abstract][Full Text] [Related]
2. Systemic Inflammatory Response in Predicting Prostate Cancer: The Diagnostic Value of Neutrophil-To-Lymphocyte Ratio.
Adhyatma KP; Prapiska FF; Siregar GP; Warli SM
Open Access Maced J Med Sci; 2019 May; 7(10):1628-1630. PubMed ID: 31210812
[TBL] [Abstract][Full Text] [Related]
3. Role of Neutrophil to Lymphocyte Ratio or Platelet to Lymphocyte Ratio in Prediction of Bone Metastasis of Prostate Cancer.
Zhang JY; Ge P; Zhang PY; Zhao M; Ren L
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115239
[TBL] [Abstract][Full Text] [Related]
4. Role of inflammatory factors in prediction of Gleason score and its upgrading in localized prostate cancer patients after radical prostatectomy.
Wang S; Ji Y; Ma J; Du P; Cao Y; Yang X; Yu Z; Yang Y
Front Oncol; 2022; 12():1079622. PubMed ID: 36713540
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Effectiveness of Neutrophil-to-lymphocyte Ratio (NLR) as a Predictive Factor in Patients Undergoing Prostate Biopsy With Prostate Specific Antigen (PSA) Between 4.0 and 10.0 ng/ml.
Masuda H; Mikami K; Otsuka K; Hou K; Suyama T; Araki K; Kojima S; Naya Y
In Vivo; 2021; 35(3):1641-1646. PubMed ID: 33910847
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of the monocyte-to-lymphocyte ratio in the diagnosis of prostate cancer.
Xu Z; Zhang J; Zhong Y; Mai Y; Huang D; Wei W; Huang J; Zhao P; Lin F; Jin J
Medicine (Baltimore); 2021 Sep; 100(38):e27244. PubMed ID: 34559125
[TBL] [Abstract][Full Text] [Related]
7. Can we use neutrophil to lymphocyte ratio in the diagnosis and prediction of extracapsular extension in localized prostate cancer?
Merder E; Arıman A; Dinçer S; Altunrende F
Urologia; 2022 May; 89(2):203-209. PubMed ID: 33960239
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Efficiency of Pan-Immune-Inflammation Value to Predict Prostate Cancer in Patients with Prostate-Specific Antigen between 4 and 20 ng/mL.
Zhu M; Zhou Y; Liu Z; Jiang Z; Qi W; Chen S; Wang W; Shi B; Zhu Y
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769469
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of the Platelet-To-Lymphocyte Ratio in Diagnosis of Prostate Cancer.
Yuksel OH; Urkmez A; Akan S; Yldirim C; Verit A
Asian Pac J Cancer Prev; 2015; 16(15):6407-12. PubMed ID: 26434851
[TBL] [Abstract][Full Text] [Related]
10. The Values of Systemic Immune-Inflammation Index and Neutrophil-Lymphocyte Ratio in the Localized Prostate Cancer and Benign Prostate Hyperplasia: A Retrospective Clinical Study.
Wang S; Ji Y; Chen Y; Du P; Cao Y; Yang X; Ma J; Yu Z; Yang Y
Front Oncol; 2021; 11():812319. PubMed ID: 35047413
[TBL] [Abstract][Full Text] [Related]
11. Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio.
Kaynar M; Yildirim ME; Gul M; Kilic O; Ceylan K; Goktas S
Cancer Biomark; 2015; 15(3):317-23. PubMed ID: 25586096
[TBL] [Abstract][Full Text] [Related]
12. The value of preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and red blood cell distribution width in predicting positive surgical margin after laparoscopic radical prostatectomy.
Wang H; Xie D; Wang S; Wu L; Chu Y; Yang P; He W; Wang J
Cancer Rep (Hoboken); 2024 Jan; 7(2):e1977. PubMed ID: 38258491
[TBL] [Abstract][Full Text] [Related]
13. Platelet-lymphocyte and neutrophil-lymphocyte ratios are prognostic but not predictive of response to abiraterone acetate in metastatic castration-resistant prostate cancer.
Lozano Martínez AJ; Moreno Cano R; Escobar Páramo S; Salguero Aguilar R; Gonzalez Billalabeitia E; García Fernández R; De La Fuente Muñoz I; Romero Borque A; Porras Martínez M; Lopez Soler F; Cardenas Cánovas E; Ortega Martín I
Clin Transl Oncol; 2017 Dec; 19(12):1531-1536. PubMed ID: 28718070
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of pretreatment inflammatory biomarkers as independent prognostic indicators in prostate cancer.
Sun Z; Ju Y; Han F; Sun X; Wang F
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28605139
[TBL] [Abstract][Full Text] [Related]
15. Inflammation-related indicators have a potential to increase overall quality of the prostate cancer management: a narrative review.
Zhou M; Liang J; Hui J; Xu J
Transl Androl Urol; 2023 May; 12(5):809-822. PubMed ID: 37305618
[TBL] [Abstract][Full Text] [Related]
16. The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6.
Wang H; Gu L; Wu Y; Feng D; Duan J; Wang X; Huang Y; Wu S; Chen J; Luo G; Zhang X
BMC Cancer; 2017 Sep; 17(1):629. PubMed ID: 28874127
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Platelet-To-Lymphocyte Ratio in Prostate Cancer.
Adhyatma KP; Warli SM
Open Access Maced J Med Sci; 2019 Apr; 7(7):1093-1096. PubMed ID: 31049087
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil and Platelet to Lymphocyte Ratios in Associating with Blood Glucose Admission Predict the Functional Outcomes of Patients with Primary Brainstem Hemorrhage.
Fan Z; Hao L; Chuanyuan T; Jun Z; Xin H; Sen L; Juan Q; Cao Y; Mu Y
World Neurosurg; 2018 Aug; 116():e100-e107. PubMed ID: 29689388
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].
Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321
[No Abstract] [Full Text] [Related]
20. Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate-specific Antigen in the Detection of Prostate Cancer: A Validation Study in a Biopsy-naive Patient Population.
Fascelli M; Rais-Bahrami S; Sankineni S; Brown AM; George AK; Ho R; Frye T; Kilchevsky A; Chelluri R; Abboud S; Siddiqui MM; Merino MJ; Wood BJ; Choyke PL; Pinto PA; Turkbey B
Urology; 2016 Feb; 88():125-34. PubMed ID: 26680244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
